Browsing Centre for Tumour Biology by Subject "5.1 Pharmaceuticals"
Now showing items 1-2 of 2
-
Abstract 958: Effective targeting of pancreatic ductal adenocarcinoma metastases with an integrin αvβ6-targeting peptide-drug conjugate
(American Association for Cancer Research (AACR), 2021-07-01) -
Abstract P6-10-05: Mutations in the RNA Splicing Factor SF3B1 drive endocrine therapy resistance and confer a targetable replication stress response defect through PARP inhibition
(American Association for Cancer Research (AACR), 2023-03-01)